LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 64

Search options

  1. Article ; Online: Cutaneous mastocytosis in childhood.

    Nemat, Katja / Abraham, Susanne

    Allergologie select

    2022  Volume 6, Page(s) 1–10

    Abstract: Mastocytoses are characterized by clonal proliferation of mast cells in various tissues. In childhood, cutaneous mastocytosis (CM) occurs almost exclusively. It is confined to the skin, and has a good prognosis. The most common form is the maculopapular ... ...

    Abstract Mastocytoses are characterized by clonal proliferation of mast cells in various tissues. In childhood, cutaneous mastocytosis (CM) occurs almost exclusively. It is confined to the skin, and has a good prognosis. The most common form is the maculopapular cutaneous mastocytosis (MPCM), formerly called urticaria pigmentosa. A distinction is made between a monomorphic variant of MPCM with multiple small, roundish maculopapular skin lesions and the - more common - polymorphic variant with larger lesions of variable size. One quarter of CM diagnosed in childhood are mastocytomas, which often occur solitary or at multiple sites. The diffuse variant of CM (DCM), which affects 5% of children with CM, should be distinguished from these forms. Systemic mastocytoses (SM) with mast cell infiltrates in the bone marrow or other extracutaneous tissues, such as the gastrointestinal tract, occur predominantly in adults. The diagnosis of CM is usually made clinically: Manifestation in infancy, typical morphology and distribution, pathognomonic Darier sign. Basal serum tryptase is determined if DCM or systemic mastocytosis are to be diagnosed. Children with mastocytosis should be managed in a specialized outpatient clinic. For affected families, detailed information about the clinical picture including prognosis assessment is essential. Mast cell mediated symptoms are controlled by oral non-sedating antihistamines if needed.
    Language English
    Publishing date 2022-01-05
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 2893503-2
    ISSN 2512-8957 ; 2512-8957
    ISSN (online) 2512-8957
    ISSN 2512-8957
    DOI 10.5414/ALX02304E
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Thesis: Auswirkungen hoher natürlicher Ozonimmissionen auf das Lungenwachstum von Schulkindern über einen Zeitraum von 1,5 Jahren

    Nemat, Katja

    2000  

    Author's details vorgelegt von Katja Nemat
    Language German
    Size 90, XIII, [28] Bl., graph. Darst.
    Edition [Mikrofiche-Ausg.]
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Freiburg (Breisgau), Univ., Diss., 2000 (Nur beschränkt für den Austausch)
    HBZ-ID HT013306781
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  3. Article: Schwere Nahrungsmittelallergien – ist eine Toleranzinduktion möglich?

    Meister, Jochen / Nemat, Katja

    Kinder- und Jugendmedizin

    2020  Volume 20, Issue 05, Page(s) 298–304

    Abstract: Die Standardtherapie bei schweren Nahrungsmittelallergien (NMA) umfasst Karenzdiät, Ernährungsberatung sowie Ausstattung mit Notfallmedikamenten und Schulung in den Notfallplan. Aufgrund der starken Einschränkung der Lebensqualität von Patienten mit ... ...

    Abstract Die Standardtherapie bei schweren Nahrungsmittelallergien (NMA) umfasst Karenzdiät, Ernährungsberatung sowie Ausstattung mit Notfallmedikamenten und Schulung in den Notfallplan. Aufgrund der starken Einschränkung der Lebensqualität von Patienten mit schwerer Nahrungsmittelallergie sind kausale Therapieansätze wünschenswert, die eine orale Toleranz aktiv induzieren. In den letzten zwei Jahrzehnten wurden verschiedene Applikations-Routen (sublingual, oral, epikutan) einer spezifischen Immuntherapie bei Patienten mit Hühnerei-, Kuhmilch- und Erdnussallergie untersucht. Aktuelle Studien konzentrierten sich vor allem auf die orale Immuntherapie (OIT) mit Erdnuss und zeigten, dass die klinische Reaktionsschwelle durch eine wiederholte Zuführung definierter Allergenmengen tatsächlich angehoben werden konnte. Kürzlich hat die US-amerikanische Arzneimittelbehörde das Erdnuss-Pulver Palforzia als erstes Therapeutikum für Nahrungsmittelallergien bei Kindern und Jugendlichen zugelassen. Jedoch ist die Erdnuss-OIT auch mit systemischen Nebenwirkungen assoziiert. Eine Niedrigdosis-OIT zeigte ein besseres Sicherheitsprofil. Zusätzliche Studien mit direktem Vergleich verschiedener Allergendosen und Dosissteigerungs-Protokolle sind notwendig. Weiterhin müssen Langzeit-Wirksamkeit und Kosteneffektivität verschiedener Ansätze zur Induktion oraler Toleranz bewertet werden.
    Keywords Nahrungsmittelallergie ; Anaphylaxie ; Orale Toleranzinduktion ; Orale Immuntherapie (OIT) ; Epikutane Immuntherapie (EPIT) ; Sublinguale Immuntherapie (SLIT) ; Allergen-spezifische Immuntherapie (AIT) ; Food allergy ; IgE-mediated food allergy ; anaphylaxis ; oral tolerance ; oral immunotherapy (OIT) ; sublingual immunotherapy (SLIT) ; epicutaneous immunotherapy (EPIT) ; allergen immunotherapy (AIT)
    Language German
    Publishing date 2020-10-01
    Publisher © Georg Thieme Verlag KG Stuttgart · New York
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2223494-9
    ISSN 2567-577X ; 1617-0288
    ISSN (online) 2567-577X
    ISSN 1617-0288
    DOI 10.1055/a-1237-0822
    Database Thieme publisher's database

    More links

    Kategorien

  4. Article: Schwere Nahrungsmittelallergien - ist eine Toleranzinduktion möglich?

    Meister, Jochen / Nemat, Katja

    Kinder- und Jugendmedizin

    2020  Volume 20, Issue 5, Page(s) 298

    Language German
    Document type Article
    ZDB-ID 2045632-3
    ISSN 1617-0288
    Database Current Contents Medicine

    More links

    Kategorien

  5. Article: Fortbildung. Nachdruck: Verschreibungsfähigkeit von wirkstofffreien Externa bei Neurodermitis

    Nemat, Katja

    Kinder- und Jugendarzt

    2013  Volume 44, Issue 5, Page(s) 229

    Language German
    Document type Article
    ZDB-ID 1461570-8
    ISSN 1436-9559 ; 0340-5877
    Database Current Contents Medicine

    More links

    Kategorien

  6. Article: Kinder mit Stichreaktionen. War's die Biene oder die Wespe?

    Nemat, Katja

    Pädiatrie

    2011  Volume 23, Issue 4, Page(s) 320

    Language German
    Document type Article
    ZDB-ID 2440229-1
    ISSN 1867-2132 ; 1437-1782
    Database Current Contents Medicine

    More links

    Kategorien

  7. Article ; Online: S3-Leitlinie Atopische Dermatitis: Teil 2 - Systemische Therapie: S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.

    Werfel, Thomas / Heratizadeh, Annice / Aberer, Werner / Augustin, Matthias / Biedermann, Tilo / Bauer, Andrea / Fölster-Holst, Regina / Kahle, Julia / Kinberger, Maria / Nemat, Katja / Neustädter, Irena / Peters, Eva / von Kiedrowski, Ralph / Schmid-Grendelmeier, Peter / Schmitt, Jochen / Schwennesen, Thomas / Simon, Dagmar / Spindler, Thomas / Traidl-Hoffmann, Claudia /
    Werner, Ricardo Niklas / Wollenberg, Andreas / Worm, Margitta / Ott, Hagen

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

    2024  Volume 22, Issue 2, Page(s) 307–322

    MeSH term(s) Humans ; Dermatitis, Atopic/diagnosis ; Dermatitis, Atopic/drug therapy ; Administration, Cutaneous
    Language English
    Publishing date 2024-02-15
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2093479-8
    ISSN 1610-0387 ; 1610-0379
    ISSN (online) 1610-0387
    ISSN 1610-0379
    DOI 10.1111/ddg.15229_g
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groups.

    Werfel, Thomas / Heratizadeh, Annice / Aberer, Werner / Augustin, Matthias / Biedermann, Tilo / Bauer, Andrea / Fölster-Holst, Regina / Kahle, Julia / Kinberger, Maria / Nemat, Katja / Neustädter, Irena / Peters, Eva / von Kiedrowski, Ralph / Schmid-Grendelmeier, Peter / Schmitt, Jochen / Schwennesen, Thomas / Simon, Dagmar / Spindler, Thomas / Traidl-Hoffmann, Claudia /
    Werner, Ricardo Niklas / Wollenberg, Andreas / Worm, Margitta / Ott, Hagen

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

    2024  Volume 22, Issue 1, Page(s) 137–153

    Abstract: This S3 guideline was created based on the European S3 guideline, with special consideration of the medical conditions in the German-speaking region and incorporating additions from the previous German-language version. The interdisciplinary guideline ... ...

    Abstract This S3 guideline was created based on the European S3 guideline, with special consideration of the medical conditions in the German-speaking region and incorporating additions from the previous German-language version. The interdisciplinary guideline commission consisted of representatives from the German Dermatological Society, the Professional Association of German Dermatologists, the Austrian Society of Dermatology and Venereology, the Swiss Society of Dermatology and Venereology, the German Society for Allergology and Clinical Immunology, the German Society for Pediatric and Adolescent Medicine, the Professional Association of Pediatricians and Adolescent Medicine, the Society for Pediatric Allergology and Environmental Medicine, the German Society for Pediatric Rehabilitation and Prevention, the German Society for Psychosomatic Medicine and Medical Psychotherapy, the German Network for Health Services Research, the German Eczema Association and the German Allergy and Asthma Association. This first part of the guideline focuses on the definition and diagnostic aspects of atopic dermatitis (AD), addressing topical therapy as well as non-pharmacological treatment approaches such as UV therapy, psychoeducational therapy, dietary interventions for AD, allergen immunotherapy for AD, and complementary medicine. This part of the guideline also covers specific aspects of AD in children and adolescents, during pregnancy and lactation, and in the context of family planning. Additionally, it addresses occupational aspects of AD and highlights the perspective of the patients. The second part of the guideline, published separately, addresses the systemic therapy of AD.
    MeSH term(s) Adolescent ; Female ; Pregnancy ; Humans ; Child ; Dermatitis, Atopic/therapy ; Dermatitis, Atopic/drug therapy ; Asthma
    Language English
    Publishing date 2024-01-03
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2093479-8
    ISSN 1610-0387 ; 1610-0379
    ISSN (online) 1610-0387
    ISSN 1610-0379
    DOI 10.1111/ddg.15230
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Cow's milk and hen's egg anaphylaxis: A comprehensive data analysis from the European Anaphylaxis Registry.

    Cichocka-Jarosz, Ewa / Dölle-Bierke, Sabine / Jedynak-Wąsowicz, Urszula / Sabouraud-Leclerc, Dominique / Köhli, Alice / Lange, Lars / Papadopoulos, Nikolaos G / Hourihane, Jonathan / Nemat, Katja / Scherer Hofmeier, Kathrin / Hompes, Stephanie / Ott, Hagen / Lopes de Oliveira, Lucila / Spindler, Thomas / Vogelberg, Christian / Worm, Margitta

    Clinical and translational allergy

    2023  Volume 13, Issue 3, Page(s) e12228

    Abstract: Background: Cow's milk (CM) and hen's egg (HE) are leading triggers of anaphylaxis in early childhood. The aim of this study was to identify clinical phenotypes and therapeutic measures for CM anaphylaxis (CMA) compared to HE anaphylaxis (HEA) in ... ...

    Abstract Background: Cow's milk (CM) and hen's egg (HE) are leading triggers of anaphylaxis in early childhood. The aim of this study was to identify clinical phenotypes and therapeutic measures for CM anaphylaxis (CMA) compared to HE anaphylaxis (HEA) in children up to 12 years of age, based on a large pan-European dataset from the European Anaphylaxis Registry.
    Methods: Data from 2007 to 2020 on clinical phenotypes and treatment from 10 European countries, as well as Brazil, were analysed. The two-step cluster analysis was used to identify the most frequent phenotypes. For each trigger, three clusters were extracted based on sex, age, and existence of symptoms in four vitally important systems.
    Results: Altogether 284 children with CMA and 200 children with HEA were identified. They were characterised as male (69% vs. 64%), infants (65% vs. 61%), with a most frequent grade III of Ring&Messmer classification (62% vs. 64%), in CMA versus HEA, respectively. Respiratory symptoms occurred more often in CMA (91% vs. 83%, p = 0.010), especially in infants (89% vs. 79%, p = 0.008). Cardiovascular symptoms were less frequent in CMA (30% vs. 44%, p = 0.002), in both infants (33% vs. 46%, p = 0.027), and older children (25% vs. 42%, p = 0.021). The clusters extracted in the CMA group were characterised as: (1) mild dermal infants with severe GI (40%), 2. severe dermal (35%), 3. respiratory (25%). While in HEA group: 1. infants with severe GI and/or reduction of alertness (40%), (2) conjunctival (16%), (3) mild GI without conjunctivitis (44%). The severity of the reaction was independent from the amount of ingested allergen protein, regardless of trigger. The first-line adrenaline application differed between the countries (0%-92%, as well as the reasons for not administering adrenaline, p < 0.001).
    Conclusions: Despite the similarity of their age, sex, and severity grade, the clinical profiles differed between the CMA and HEA children. Adrenaline was underused, and its administration was country dependent. Further studies are needed to assess to what extent the differences in the clinical profiles are related to matrix and/or absorption effects, and/or the allergen itself.
    Language English
    Publishing date 2023-03-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2630865-4
    ISSN 2045-7022
    ISSN 2045-7022
    DOI 10.1002/clt2.12228
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.

    Werfel, Thomas / Heratizadeh, Annice / Aberer, Werner / Augustin, Matthias / Biedermann, Tilo / Bauer, Andrea / Fölster-Holst, Regina / Kahle, Julia / Kinberger, Maria / Nemat, Katja / Neustädter, Irena / Peters, Eva / von Kiedrowski, Ralph / Schmid-Grendelmeier, Peter / Schmitt, Jochen / Schwennesen, Thomas / Simon, Dagmar / Spindler, Thomas / Traidl-Hoffmann, Claudia /
    Werner, Ricardo Niklas / Wollenberg, Andreas / Worm, Margitta / Ott, Hagen

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

    2023  Volume 22, Issue 2, Page(s) 307–320

    Abstract: The present S3 guideline was created based on the European English-language S3 guideline, with special consideration given to the medical conditions in the German-speaking region, and with additions from the previous German-language version, in ... ...

    Abstract The present S3 guideline was created based on the European English-language S3 guideline, with special consideration given to the medical conditions in the German-speaking region, and with additions from the previous German-language version, in accordance with the criteria of the AWMF. This second part of the guideline addresses the systemic therapy of atopic dermatitis (AD). It covers topics such as the indication for systemic therapy in children, adolescents, and adult patients with AD. Furthermore, it addresses all medications approved for AD, such as the biologics dupilumab and tralokinumab, the Janus kinase inhibitors abrocitinib, baricitinib, and upadacitinib, as well as conventional immunosuppressive therapies with systemic glucocorticosteroids and ciclosporin. Additionally, it discusses systemic off-label therapies. The first part of the guideline, published separately, includes the definition and diagnostic aspects of AD, describes topical therapy, non-drug therapy approaches, and addresses aspects related to special patient groups.
    MeSH term(s) Adolescent ; Adult ; Child ; Humans ; Dermatitis, Atopic/diagnosis ; Dermatitis, Atopic/drug therapy ; Administration, Cutaneous ; Biological Products ; Cyclosporine ; Immunosuppression Therapy ; Treatment Outcome
    Chemical Substances Biological Products ; Cyclosporine (83HN0GTJ6D)
    Language English
    Publishing date 2023-12-31
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2093479-8
    ISSN 1610-0387 ; 1610-0379
    ISSN (online) 1610-0387
    ISSN 1610-0379
    DOI 10.1111/ddg.15229
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top